Showing page 25 of 36
Fredrikson & Byron Represents Bio-Techne Corporation in its Acquisition of Zephyrus Biosciences, Inc.
Fredrikson & Byron acted as legal counsel to Bio-Techne Corporation in its acquisition of Zephyrus Biosciences, Inc.
Fredrikson & Byron acted as legal counsel to Omnis International Co., d/b/a Omnis Pharma, in its merger with Magnis Therapeutics, LLC.
Attorney Nicholas J. Monson has joined Fredrikson & Byron as a senior associate in the Real Estate and Private Equity Groups.
Roberts advises business clients on a variety of matters, including mergers and acquisitions, compliance and general corporate governance.
Fredrikson & Byron attorneys won a hard-fought victory for Vascular Solutions’ CEO Howard Root in a federal criminal prosecution with far-reaching implications for medical device companies and FDA practitioners.
Fredrikson & Byron Obtains $12.8 Million Award for H.B. Fuller Company Against Accenture for Software Implementation Failure
Fredrikson & Byron Obtains $12.8 Million Award for H.B. Fuller Company (NYSE: FUL) in an arbitration against the consulting company Accenture for failing to lead H.B. Fuller’s global ERP (enterprise resource planning software) implementation.
Fredrikson & Byron shareholder Loan T. Huynh was named member of the 2016 class of Fellows.
The BTI Consulting Group included Fredrikson & Byron on its “Honor Roll of the Best” ranking for its client service excellence.